Literature DB >> 22108727

Cardiomyopathies: classification, diagnosis, and treatment.

Bernhard Maisch1, Michel Noutsias, Volker Ruppert, Anette Richter, Sabine Pankuweit.   

Abstract

This article comments on the recent classifications of cardiomyopathies by the American Heart Association and the European Society of Cardiology with respect to their clinical applicability. Taking them and the statement on the role of endomyocardial biopsies in different clinical scenarios together, the clinician is now able to identify genetic, autoimmune, and viral causative factors by using a thorough and logical approach to reach a diagnosis in patients with familial and nonfamilial forms of the underlying structural heart muscle diseases. In this overview, a special emphasis is also placed on the management of inflammatory and viral cardiomyopathies. 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22108727     DOI: 10.1016/j.hfc.2011.08.014

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  19 in total

1.  Disrespectful thoughts on dimensions in the outer and inner world.

Authors:  H Stormorken
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  Chromosomal regulation by MeCP2: structural and enzymatic considerations.

Authors:  N J Bowen; M B Palmer; P A Wade
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

3.  [The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy : what is new?].

Authors:  B Maisch; H Mahrholdt
Journal:  Herz       Date:  2014-12       Impact factor: 1.443

4.  Nothing new in heart failure? A current misconception!

Authors:  B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

5.  Pericardial diseases in the era of imaging, biomarkers and molecular diagnosis.

Authors:  Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 6.  Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.

Authors:  Loon Yee Louis Teo; Rocio T Moran; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2015-12

7.  Exercise and sports in cardiac patients and athletes at risk: Balance between benefit and harm.

Authors:  B Maisch
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 8.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 9.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Pericardioscopy and epi- and pericardial biopsy - a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy.

Authors:  Bernhard Maisch; Heinz Rupp; Arsen Ristic; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.